As of Feb 17
| +0.01 / +0.75%|
The 2 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +161.19% increase from the last price of 1.34.
The current consensus among 2 polled investment analysts is to Buy stock in CASI Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.